Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Kidney Int. 2013 Aug 21;85(2):404–415. doi: 10.1038/ki.2013.278

Table 3.

Predictors of last VvInt/C, last GFR, last ACR and VvInt/C Change

Last VvInt/C
Variable Estimate (95% CI) P-Value
Plasma Aldosterone 0 (0, 0) 0.47
Plasma Renin Activity −0.001 (−0.018, 0.017) 0.94
Caucasian Donor 0.044 (−0.004, 0.092) 0.07
Tacrolimus + Rapamycin 0.067 (−0.014, 0.148) 0.10
Last GFR
Plasma Aldosterone 0.01 (−0.03, 0.06) 0.62
Plasma Renin Activity 0.84 (−3.32, 4.99) 0.69
Caucasian Recipient −11.86 (−23.09, −0.64) 0.04
<3 HLA Matches −7.74 (−15.68, 0.19) 0.06
Losartan −6.78 (−14.95, 1.39) 0.10
Tacrolimus + Rapamycin −16.2 (−34.78, 2.37) 0.09
Last ACR
Plasma Aldosterone −0.36 (−1.02, 0.3) 0.28
Plasma Renin Activity 18.16 (−47.8, 84.12) 0.58
Recipient BMI 17.72 (3.09, 32.36) 0.02
Tacrolimus + MMF −322.12 (−612.94, −31.31) 0.03
Tacrolimus+ MMF + Pred. −362.28 (−750.67, 26.1) 0.07
CSA + MMF −334.44 (−635.84, −33.04) 0.03
CSA + MMF + Pred. −401.41 (−715.09, −87.73) 0.01
VvInt/C Change
Plasma Aldosterone 0 (0, 0) 0.61
Plasma Renin Activity −0.001 (−0.034, 0.033) 0.96
Acute Rejection 0.085 (−0.006, 0.175) 0.06
*

BMI: body mass index; CSA: Cyclosporine, MMF: mycophenolate mofetil, Pred.: Prednisone.